Stay updated on ALS Safety & Tolerability of Triumeq Clinical Trial
Sign up to get notified when there's something new on the ALS Safety & Tolerability of Triumeq Clinical Trial page.

Latest updates to the ALS Safety & Tolerability of Triumeq Clinical Trial page
- Check6 days agoChange DetectedThe page now shows Revision: v3.5.4 in the footer, replacing the previous Revision: v3.5.3. This indicates a minor update to the page rather than any change to the study details.SummaryDifference0.1%

- Check13 days agoNo Change Detected
- Check20 days agoChange DetectedThe page's revision label was updated from v3.5.2 to v3.5.3, indicating a newer page build. This appears to be a maintenance/versioning update rather than a change to study content.SummaryDifference0.1%

- Check27 days agoNo Change Detected
- Check34 days agoChange DetectedRevision updated to v3.5.2; the previous version shown was v3.5.0.SummaryDifference0.1%

- Check63 days agoChange DetectedRevision updated to v3.5.0; the previous version v3.4.3 was removed.SummaryDifference0.1%

- Check70 days agoChange DetectedAdded University of Sydney as a collaborator and removed the Brain and Mind Centre under The University of Sydney from the collaborators list.SummaryDifference0.1%

- Check99 days agoChange DetectedRevision: v3.4.2 was added and the government funding status notice was removed. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.4%

Stay in the know with updates to ALS Safety & Tolerability of Triumeq Clinical Trial
Enter your email address, and we'll notify you when there's something new on the ALS Safety & Tolerability of Triumeq Clinical Trial page.